Pressmeddelanden
Coegin Pharma receives first purchase order for new scalp serum
Coegin Pharma AB ("Coegin" or the "Company") today announces that it has received its first limited purchase order for the Company's newly introduced high-performance cosmetic sc...
Coegin Pharma accelerates Follicopeptide® portfolio expansion with a new high-performance scalp serum
Coegin Pharma AB ("Coegin") today announces further details on the launch of a new high-performance cosmetic scalp serum developed to optimize the scalp environment. The product...
REG
Coegin Pharma AB (publ) publishes its year-end report for 2025
Summary of year-end report 2025With products on the market, strengthened financing and a growing platform strategy, Coegin Pharma enters 2026 from a significantly stronger positi...
REG
MAR
Coegin Pharma carries out directed issues totalling approx. SEK 12.1 million and strengthens the Company's liquidity position
The Board of Directors of Coegin Pharma AB (publ) (the "Company" or "Coegin Pharma") has today resolved to carry out directed issues totalling up to approximately SEK 12.1 millio...
Coegin Pharma provides an operational and strategic update
Coegin Pharma AB ("Coegin" or the "Company") today provides an operational and strategic update regarding its commercialization activities and business planning.
Operational upda...
Coegin Pharma appoints worldleading pigmentation and hair-biology expert Professor Desmond J. Tobin as Scientific Advisor
Coegin Pharma AB ("Coegin") is delighted to announce that Professor Desmond J. Tobin, a globally recognized leader in skin and hair pigmentation science and hair-follicle biology...
Rapporter
Video
Finansiell kalender
Om Coegin Pharma
Coegin Pharma är ett svenskt bioteknikföretag som utvecklar banbrytande innovationer för hår och hud.
Webbplats
www.coeginpharma.com
Bransch
Bioteknik
Prenumerera
Få löpande information från Coegin Pharma via e-post.
Handelsinformation
Kurs 3,71 SEK (2026-03-06)
Förändring −14,32% (2025-03-06)